China guiding outline on cardiovascular disease prevention
Zhao, D.
Zhonghua Xin Xue Guan Bing Za Zhi 41(7): 538-539
2013
ISSN/ISBN: 0253-3758 PMID: 24284180 Document Number: 666160
Document emailed within 1 workday
Related Documents
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Kleinert, S. 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation Lancet 354(9181): 841
Hu, D-Yi. 2013: Consensus recommendation on the development of cardiovascular disease polypill in China Zhonghua Xin Xue Guan Bing Za Zhi 41(2): 91-93
Qu, G.; Li, J. 1990: An outline of study on China's population / environment issues China Population Newsletter 7(5): 2-4
Gallagher, L.G.; Davis, L.B.; Ray, R.M.; Psaty, B.M.; Gao, D.L.; Checkoway, H.; Thomas, D.B. 2011: Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China International Journal of Epidemiology 40(6): 1510-1518
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Yin, X-jun.; Shi, X-ming.; Si, X.; Gao, X.; Zhai, Y. 2010: Assessment of capacity for chronic noncommunicable diseases prevention and control of the Center for Disease Control and Prevention Organizations in China Zhonghua Liu Xing Bing Xue Za Zhi 31(10): 1125-1129
Garrett, R.E. 1986: Primary prevention of cardiovascular disease Journal of Family Practice 22(3): 222 224
Raffoul, M.; Lin, K.W. 2016: Influenza Vaccination for the Prevention of Cardiovascular Disease American Family Physician 93(5): 357-358
Birkeland, K.I.; Claudi, T.; Hansteen, V.; Hanssen, K.F.; Hjermann, I.; Jenssen, T.; Jervell, J.; Os, I. 2000: Prevention of cardiovascular disease in type 2 diabetes Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(21): 2554-2559
Bonow, R.O. 2004: Prevention of cardiovascular disease: challenges and opportunities Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5 Suppl. 6: 6s-8s
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Adamus, J.; Kałka, D. 2007: Physical activity in prevention of cardiovascular disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 22(127): 5-8
Cheng, T.O. 1991: Prevention better than treatment of heart disease in China Medical Journal of Australia 154(3): 224
Yokota, C. 2003: Prevention of cardiovascular disease in type 2 diabetic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1161-1166
Wander, G.S.; Hukkeri, M.Yunus.Khan.; Yalagudri, S.; Mahajan, B.; Panda, A.Toppo. 2018: Rosuvastatin: Role in Secondary Prevention of Cardiovascular Disease Journal of the Association of Physicians of India 66(3): 70-74
García-Palmieri, M.R. 2000: Primary and secondary prevention of cardiovascular disease in the elderly Boletin de la Asociacion Medica de Puerto Rico 92(1-3): 3-8
McCarthy, M. 2013: New US prevention guidelines focus on overall risk of cardiovascular disease Bmj 347: F6858
Hernández Figueroa, T.T.; Rodríguez-Rodríguez, E.; Sánchez-Muniz, F.J. 2004: The green tea, a good choice for cardiovascular disease prevention? Archivos Latinoamericanos de Nutricion 54(4): 380-394